Use of oral sildenafil in patients with irreversible pulmonary hypertension not eligible for heart transplantation

Transplantation Proceedings

Volumn 37, Issue 3, 2005, Pages 1550-1551

  Gomez Moreno S ^a,b   Lage, E ^a   Hernandez A ^a   Campos, A ^a   Cabezon S ^a   Ordonez A ^a   Hinojosa, R ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

SILDENAFIL;

ADULT; ANAMNESIS; BECKER MUSCULAR DYSTROPHY; CASE REPORT; CONFERENCE PAPER; ECHOCARDIOGRAPHY; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; PULMONARY ARTERY; SYSTOLIC BLOOD PRESSURE;

ADMINISTRATION, ORAL; ADULT; BLOOD PRESSURE; CARDIAC OUTPUT; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; HEART RATE; HEART TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; MALE; PATIENT SELECTION; PIPERAZINES; PULMONARY CIRCULATION; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 19044373589     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.02.013     Document Type: Conference Paper

References (5)

1. Mudge GH, Goldstein S, Addonizio LJ,, et al. Twenty-Fourth Bethesda Conference. Cardiac transplantation. Task force 3: recipient guidelines/prioritation. J Am Coll Cardiol 22:21, 1993
2. A. Costard-Jackle, J.S. Shroeder, M.B. Folwer The influence of preoperative patient characteristics on early and late survival following cardiac transplantation Circulation 84 suppl 3 1991 III-329
3. E. Michelakis, W. Tymchak, D. Lien Oral sildenafil is an effective and specific pulmonary vasodilatador in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide Circulation 105 2002 2398
4. J.J. Lepore, N. Pereira, A. Maroo Sildenafil is a pulmonary vasodilatador by inhaled nitric oxide in patients with pulmonary hypertension Circulation 100 1999 I-240
5. P. Escribano, M. Lázaro, S. Fernández Tratamiento médico de la hipertensión pulmonar Rev Esp Cardiol Suppl 2 2002 33C